KERX DEADLINE: Hagens Berman Reminds Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) of October 3, 2016 Lead Plaintiff Deadline and of Expanded Securities Case Class Period
September 08, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) of the October 3, 2016 Lead Plaintiff deadline...
Hagens Berman Reminds Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) of October 3, 2016 Lead Plaintiff Deadline in Securities Class Action
August 18, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) to a pending securities class action filed in the...
INVESTOR ALERT: Hagens Berman Alerts Investors in Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) to October 3, 2016 Lead Plaintiff Deadline in Securities Class Action
August 04, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) to a pending securities class action filed in the...